{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:15:47Z","timestamp":1788243347563,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,31]]},"DOI":"10.7759\/cureus.115565","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T05:43:28Z","timestamp":1788241408000},"source":"Crossref","is-referenced-by-count":0,"title":["Impact of Gastric Acid Suppression on Clostridioides difficile Infection: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Ajay Kausheic","family":"Madhusuthanan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Afzal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Turuzhbaeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mithum","family":"Senaratne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Ajal Loueian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Summayya","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1408913","article-title":"Burden of Clostridium difficile infection in the United States","volume":"372","author":"Lessa FC","year":"2015","unstructured":"Lessa FC, Mu Y, Bamberg WM, et al.. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015, 372:825-34. 10.1056\/NEJMoa1408913","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1586\/egh.10.48","article-title":"The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings","volume":"4","author":"Khanna S","year":"2010","unstructured":"Khanna S, Pardi DS. The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings. Expert Rev Gastroenterol Hepatol. 2010, 4:409-16. 10.1586\/egh.10.48","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/gut.28.1.96","article-title":"Relationship between gastric secretion and infection","volume":"28","author":"Howden CW","year":"1987","unstructured":"Howden CW, Hunt RH. Relationship between gastric secretion and infection. Gut. 1987, 28:96-107. 10.1136\/gut.28.1.96","journal-title":"Gut"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.06.043","article-title":"Proton pump inhibitors alter specific taxa in the human gastrointestinal microbiome: a crossover trial","volume":"149","author":"Freedberg DE","year":"2015","unstructured":"Freedberg DE, Toussaint NC, Chen SP, et al.. Proton pump inhibitors alter specific taxa in the human gastrointestinal microbiome: a crossover trial. Gastroenterology. 2015, 149:883-5.e9. 10.1053\/j.gastro.2015.06.043","journal-title":"Gastroenterology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.179","article-title":"Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis","volume":"107","author":"Janarthanan S","year":"2012","unstructured":"Janarthanan S, Ditah I, Adler DG, Ehrinpreis MN. Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis. Am J Gastroenterol. 2012, 107:1001-10. 10.1038\/ajg.2012.179","journal-title":"Am J Gastroenterol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2011.09.030","article-title":"Association between proton pump inhibitor therapy and Clostridium difficile infection in a meta-analysis","volume":"10","author":"Deshpande A","year":"2012","unstructured":"Deshpande A, Pant C, Pasupuleti V, et al.. Association between proton pump inhibitor therapy and Clostridium difficile infection in a meta-analysis. Clin Gastroenterol Hepatol. 2012, 10:225-33. 10.1016\/j.cgh.2011.09.030","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1857","article-title":"Proton-pump inhibitor use and the risk of community-associated Clostridium difficile infection","volume":"72","author":"Inghammar M","year":"2021","unstructured":"Inghammar M, Svanstr\u00f6m H, Voldstedlund M, Melbye M, Hviid A, M\u00f8lbak K, Pasternak B. Proton-pump inhibitor use and the risk of community-associated Clostridium difficile infection. Clin Infect Dis. 2021, 72:e1084-9. 10.1093\/cid\/ciaa1857","journal-title":"Clin Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2021.01.008","article-title":"Proton pump inhibitor use and risk for recurrent Clostridioides difficile infection: a systematic review and meta-analysis","volume":"Online ahead of print","author":"D'Silva KM","year":"2021","unstructured":"D'Silva KM, Mehta R, Mitchell M, Lee TC, Singhal V, Wilson MG, McDonald EG. Proton pump inhibitor use and risk for recurrent Clostridioides difficile infection: a systematic review and meta-analysis. Clin Microbiol Infect. 2021, Online ahead of print:10.1016\/j.cmi.2021.01.008","journal-title":"Clin Microbiol Infect"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-023-02895-w","article-title":"Meta-analysis of the effects of proton pump inhibitors on the human gut microbiota","volume":"23","author":"Zhang J","year":"2023","unstructured":"Zhang J, Zhang C, Zhang Q, Yu L, Chen W, Xue Y, Zhai Q. Meta-analysis of the effects of proton pump inhibitors on the human gut microbiota. BMC Microbiol. 2023, 23:171. 10.1186\/s12866-023-02895-w","journal-title":"BMC Microbiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkae012","article-title":"The combined effect of systemic antibiotics and proton pump inhibitors on Clostridioides difficile infection and recurrence","volume":"79","author":"Moreels N","year":"2024","unstructured":"Moreels N, Boven A, Gressani O, et al.. The combined effect of systemic antibiotics and proton pump inhibitors on Clostridioides difficile infection and recurrence. J Antimicrob Chemother. 2024, 79:608-16. 10.1093\/jac\/dkae012","journal-title":"J Antimicrob Chemother"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2010.73","article-title":"Proton pump inhibitors and risk for recurrent Clostridium difficile infection","volume":"170","author":"Linsky A","year":"2010","unstructured":"Linsky A, Gupta K, Lawler EV, Fonda JR, Hermos JA. Proton pump inhibitors and risk for recurrent Clostridium difficile infection. Arch Intern Med. 2010, 170:772-8. 10.1001\/archinternmed.2010.73","journal-title":"Arch Intern Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2013.04.047","article-title":"Acid suppression and the risk of Clostridium difficile infection","volume":"163","author":"Mezoff EA","year":"2013","unstructured":"Mezoff EA, Cohen MB. Acid suppression and the risk of Clostridium difficile infection. J Pediatr. 2013, 163:627-30. 10.1016\/j.jpeds.2013.04.047","journal-title":"J Pediatr"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.01.031","article-title":"The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association","volume":"152","author":"Freedberg DE","year":"2017","unstructured":"Freedberg DE, Kim LS, Yang YX. The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association. Gastroenterology. 2017, 152:706-15. 10.1053\/j.gastro.2017.01.031","journal-title":"Gastroenterology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/0009922815569201","article-title":"Acid-suppressing agents and risk for Clostridium difficile infection in pediatric patients","volume":"54","author":"Brown KE","year":"2015","unstructured":"Brown KE, Knoderer CA, Nichols KR, Crumby AS. Acid-suppressing agents and risk for Clostridium difficile infection in pediatric patients. Clin Pediatr (Phila). 2015, 54:1102-6. 10.1177\/0009922815569201","journal-title":"Clin Pediatr (Phila)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2025.106488","article-title":"Proton pump inhibitors and the risk of Clostridioides difficile infection: a systematic review and dose-response meta-analysis","volume":"90","author":"Finke M","year":"2025","unstructured":"Finke M, Boven A, Vlieghe E, Engstrand L, Orsini N, Brusselaers N. Proton pump inhibitors and the risk of Clostridioides difficile infection: a systematic review and dose-response meta-analysis. J Infect. 2025, 90:106488. 10.1016\/j.jinf.2025.106488","journal-title":"J Infect"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.12775\/JEHS.2023.48.01.001","article-title":"Proton pump inhibitor (PPI) administration and Clostridioides difficile infection-is this a real clinical problem? A critical review of the literature","volume":"48","author":"G\u0142az A","year":"2023","unstructured":"G\u0142az A, Knop K, Kochanowska A, et al.. Proton pump inhibitor (PPI) administration and Clostridioides difficile infection-is this a real clinical problem? A critical review of the literature. J Educ Health Sport. 2023, 48:11-22. 10.12775\/JEHS.2023.48.01.001","journal-title":"J Educ Health Sport"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2022.12.002","article-title":"Deprescribing antacids after the diagnosis of Clostridioides difficile infection: a single-center observational study","volume":"29","author":"Okamoto K","year":"2023","unstructured":"Okamoto K, Harada T, Kosaka S, Kutsuna S. Deprescribing antacids after the diagnosis of Clostridioides difficile infection: a single-center observational study. J Infect Chemother. 2023, 29:232-4. 10.1016\/j.jiac.2022.12.002","journal-title":"J Infect Chemother"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-024-00922-5","article-title":"Association between risk of Clostridium difficile infection and duration of proton pump inhibitor or H2-receptor antagonist use in hospitalized patients","volume":"13","author":"Huang CH","year":"2024","unstructured":"Huang CH, Tseng YH, Tsai WS, et al.. Association between risk of Clostridium difficile infection and duration of proton pump inhibitor or H2-receptor antagonist use in hospitalized patients. Infect Dis Ther. 2024, 13:373-83. 10.1007\/s40121-024-00922-5","journal-title":"Infect Dis Ther"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.23.2989","article-title":"Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease","volume":"294","author":"Dial S","year":"2005","unstructured":"Dial S, Delaney JA, Barkun AN, Suissa S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA. 2005, 294:2989-95. 10.1001\/jama.294.23.2989","journal-title":"JAMA"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2010.89","article-title":"Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection","volume":"170","author":"Howell MD","year":"2010","unstructured":"Howell MD, Novack V, Grgurich P, Soulliard D, Novack L, Pencina M, Talmor D. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. Arch Intern Med. 2010, 170:784-90. 10.1001\/archinternmed.2010.89","journal-title":"Arch Intern Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2008.04.023","article-title":"Is over-use of proton pump inhibitors fuelling the current epidemic of Clostridium difficile-associated diarrhoea?","volume":"70","author":"Cunningham R","year":"2008","unstructured":"Cunningham R, Dial S. Is over-use of proton pump inhibitors fuelling the current epidemic of Clostridium difficile-associated diarrhoea?. J Hosp Infect. 2008, 70:1-6. 10.1016\/j.jhin.2008.04.023","journal-title":"J Hosp Infect"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.108","article-title":"Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis","volume":"107","author":"Kwok CS","year":"2012","unstructured":"Kwok CS, Arthur AK, Anibueze CI, Singh S, Cavallazzi R, Loke YK. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis. Am J Gastroenterol. 2012, 107:1011-9. 10.1038\/ajg.2012.108","journal-title":"Am J Gastroenterol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04874.x","article-title":"Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection","volume":"34","author":"Bavishi C","year":"2011","unstructured":"Bavishi C, Dupont HL. Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection. Aliment Pharmacol Ther. 2011, 34:1269-81. 10.1111\/j.1365-2036.2011.04874.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.5009\/gnl16438","article-title":"Does long-term proton pump inhibitor therapy affect the health of gut microbiota?","volume":"10","author":"Lee C","year":"2016","unstructured":"Lee C, Hong SN. Does long-term proton pump inhibitor therapy affect the health of gut microbiota?. Gut Liver. 2016, 10:865-6. 10.5009\/gnl16438","journal-title":"Gut Liver"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2017.0212","article-title":"Association of gastric acid suppression with recurrent Clostridium difficile infection: a systematic review and meta-analysis","volume":"177","author":"Tariq R","year":"2017","unstructured":"Tariq R, Singh S, Gupta A, Pardi DS, Khanna S. Association of gastric acid suppression with recurrent Clostridium difficile infection: a systematic review and meta-analysis. JAMA Intern Med. 2017, 177:784-91. 10.1001\/jamainternmed.2017.0212","journal-title":"JAMA Intern Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2015.42","article-title":"Continuous proton pump inhibitor therapy and the associated risk of recurrent Clostridium difficile infection","volume":"175","author":"McDonald EG","year":"2015","unstructured":"McDonald EG, Milligan J, Frenette C, Lee TC. Continuous proton pump inhibitor therapy and the associated risk of recurrent Clostridium difficile infection. JAMA Intern Med. 2015, 175:784-91. 10.1001\/jamainternmed.2015.42","journal-title":"JAMA Intern Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-310376","article-title":"Proton pump inhibitors affect the gut microbiome","volume":"65","author":"Imhann F","year":"2016","unstructured":"Imhann F, Bonder MJ, Vich Vila A, et al.. Proton pump inhibitors affect the gut microbiome. Gut. 2016, 65:740-8. 10.1136\/gutjnl-2015-310376","journal-title":"Gut"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2010.190","article-title":"Clostridium difficile infection: epidemiology, risk factors and management","volume":"8","author":"Ananthakrishnan AN","year":"2011","unstructured":"Ananthakrishnan AN. Clostridium difficile infection: epidemiology, risk factors and management. Nat Rev Gastroenterol Hepatol. 2011, 8:17-26. 10.1038\/nrgastro.2010.190","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-020-01671-1","article-title":"Correction to: Magnitude and direction of the association between Clostridium difficile infection and proton pump inhibitors in adults and pediatric patients: a systematic review and meta-analysis","volume":"55","author":"Oshima T","year":"2020","unstructured":"Oshima T, Wu L, Li M, Fukui H, Watari J, Miwa H. Correction to: Magnitude and direction of the association between Clostridium difficile infection and proton pump inhibitors in adults and pediatric patients: a systematic review and meta-analysis. J Gastroenterol. 2020, 55:475-80. 10.1007\/s00535-020-01671-1","journal-title":"J Gastroenterol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i35.6500","article-title":"Proton pump inhibitors therapy and risk of Clostridium difficile infection: systematic review and meta-analysis","volume":"23","author":"Trifan A","year":"2017","unstructured":"Trifan A, Stanciu C, Girleanu I, et al.. Proton pump inhibitors therapy and risk of Clostridium difficile infection: systematic review and meta-analysis. World J Gastroenterol. 2017, 23:6500-15. 10.3748\/wjg.v23.i35.6500","journal-title":"World J Gastroenterol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/444270-impact-of-gastric-acid-suppression-on-clostridioides-difficile-infection-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T05:43:29Z","timestamp":1788241409000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/444270-impact-of-gastric-acid-suppression-on-clostridioides-difficile-infection-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.115565","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,31]]}}}